Enzalutamide monotherapy in patients with hormone-naïve prostate cancer: 1.year extended follow-up of a phase 2 study.

Michael Borre, Matthew Smith, Per Rathenborg, Patrick Werbrouck, Hendrik van Poppel, Axel Heidenreich, Peter Iversen, Johan Braeckman, Jiri Heracek, Edwina Baskin-Bey, Taoufik Ouatas, Frank Perabo, D. Phung, Benoit Baron, Mohammad Hirmand, Bertrand Tombal

OriginalsprogEngelsk
ArtikelnummerP060
TidsskriftEuropean Urology Supplements
Vol/bind13
Udgave nummer131
Sider (fra-til)131
ISSN1569-9056
StatusUdgivet - 2014

Citationsformater